PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#Quad Pharms ×

UPDATED
Regulatory Updates
Sep 8, 2026•1 min read
Quad Pharms Isoniazid Injection (100 mg/mL) Listed as Discontinued in FDA ANDA089816
FDA records show Quad Pharms' Isoniazid injectable (100 mg/mL) under ANDA089816 is marked as discontinued.
1
UPDATED
Regulatory Updates
Aug 30, 2026•1 min read
FDA Discontinues Methotrexate Sodium Injection (ANDA089309)
The FDA has listed Quad Pharms' methotrexate sodium injection (product 001) as discontinued under ANDA089309.